Scar Treatment Market - Forecasts from 2019 to 2024

June 2019 | 107 pages | ID: S1C0F1531FDDEN
Knowledge Sourcing Intelligence LLP

Abstracts

The scar treatment market is estimated to witness a CAGR of 11.45% to reach US$21,678.028 million in 2024 from US$11,313.217 million in 2018. Scarring is part of the healing process after an injury. There are different types of scars including Keloid scar, contracture scar, hypertrophic scar, and acne scar. Their appearance and treatment depend on multiple factors. Treatments include laser treatment, using topical products and injectables.

Rising awareness among people regarding aesthetics and a rising number of roads accidents are considered as the driving factor for the growth of the market. Technological advancement in scar treatment products makes the whole process of treatment painless and hassle-free which further fuels up the growth of the market. However high cost involved in laser-based products is considered as the restraining factor for the growth of the market.

On the basis of scar type, keloid and contracture segment is expected to have significant market share because these scars hamper movement and incidence of burn injury is also on the rise. By treatment type, topical products are expected to have a significant market share as its application is easy and the cost is low. Asia Pacific region is expected to grow with high CAGR owing to growing awareness and treatment in developing countries like China, Japan, and India.

DRIVERS

• Technological advancement in scar treatment products
• Growing awareness among people regarding the appearance
• A rising number of road accidents and burn injuries

RESTRAINTS

• High cost involved in laser-based treatments

INDUSTRY UPDATES

• In November 2018, The Scar Free Foundation Centre for Conflict Wound Research opened at Queen Elizabeth Hospital in Birmingham to develop innovative new treatments for patients affected by scar-related injuries.
• New Insights on anti-scarring treatment was published in Nature communications in February 2019. It has been discovered that the natural scar-free skin repair process relies partially on assistance from circulating blood cells.
• In October 2018, a study was published in the prestigious international peer-reviewed ‘Plastic and Reconstructive Surgery Journal' of the American Society of Plastic Surgeons regarding a new technique to treat complex scars and surgery wounds.

SEGMENTATION

The scar treatment market has been analyzed through the following segments:

• By scar type
• Keloid scars
• Contracture scars
• Hypertrophic scars
• Acne scars
• By treatment type
• Topical Products
• Laser Treatment
• Injectables
• By Geography
• North America
• USA
• Canada
• Mexico
• South America
• Brazil
• Argentina
• Others
• Europe
• Germany
• France
• United Kingdom
• Spain
• Others
• Middle East and Africa
• Saudi Arabia
• Israel
• Others
• Asia Pacific
• China
• Japan
• South Korea
• India
• Others

Contents

1. INTRODUCTION

1.1. Market Overview
1.2. Market Definition
1.3. Scope of the Study
1.4. Currency
1.5. Assumptions
1.6. Base, and Forecast Years Timeline

2. RESEARCH METHODOLOGY

2.1. Research Design
2.2. Secondary Sources

3. KEY FINDINGS

4. MARKET DYNAMICS

4.1. Market Segmentation
4.2. Market Drivers
4.3. Market Restraints
4.4. Market Opportunities
4.5. Porter’s Five Forces Analysis
  4.5.1. Bargaining Power of Suppliers
  4.5.2. Bargaining Power of Buyers
  4.5.3. Threat of New Entrants
  4.5.4. Threat of Substitutes
  4.5.5. Competitive Rivalry in the Industry
4.6. Life Cycle Analysis - Regional Snapshot
4.7. Market Attractiveness

5. SCAR TREATMENT MARKET BY SCAR TYPE

5.1. Keloid scars
5.2. Contracture scars
5.3. Hypertrophic scars
5.4. Acne scars

6. SCAR TREATMENT MARKET BY TREATMENT TYPE

6.1. Topical Products
6.2. Laser Treatment
6.3. Injectables

7. SCAR TREATMENT MARKET BY DISTRIBUTION CHANNEL

7.1. Online
7.2. Offline

8. SCAR TREATMENT MARKET BY GEOGRAPHY

8.1. North America
  8.1.1. USA
  8.1.2. Canada
  8.1.3. Mexico
8.2. South America
  8.2.1. Brazil
  8.2.2. Argentina
  8.2.3. Others
8.3. Europe
  8.3.1. Germany
  8.3.2. France
  8.3.3. United Kingdom
  8.3.4. Spain
  8.3.5. Others
8.4. Middle East and Africa
  8.4.1. Saudi Arabia
  8.4.2. Israel
  8.4.3. Others
8.5. Asia Pacific
  8.5.1. China
  8.5.2. Japan
  8.5.3. South Korea
  8.5.4. India
  8.5.5. Others

9. COMPETITIVE INTELLIGENCE

9.1. Competitive Benchmarking and Analysis
9.2. Recent Investments and Deals
9.3. Strategies of Key Players

10. COMPANY PROFILES

10.1. CCA Industries Inc.
10.2. Cynosure, Inc.
10.3. Clariant AG
10.4. Smith & Nephew plc
10.5. Sientra
10.6. Lumenis
10.7. Merz pharma
10.8. Sonoma Pharmaceuticals, Inc.
10.9. Scar Heal Inc.
10.10. NewMedical Technology, Inc.
LIST OF FIGURES
LIST OF TABLES